Catherine Bollard

Catherine Bollard

Directeur/Membre du Conseil chez CABALETTA BIO, INC.

Fortune : 16 810 $ au 30/06/2026

58 ans
Consumer Services
Commercial Services
Health Services

Profil

Catherine Bollard is the founder of Mana Therapeutics, Inc. Current positions include Program Director at Children's National Hospital (District of Columbia) since 2013, Director at Alliance for Regenerative Medicine since 2023, Independent Director at Cabaletta Bio, Inc. since 2019, and Professor at George Washington University since 2013.
Former roles include Director-Center for Cancer at Children's Research Institute, Inc., Director at The Foundation For The Accreditation of Cellular Therapy, Director-Translational Research & Innovation at GW Cancer Center, President of the International Society for Cellular Therapy, and Professor at Baylor College of Medicine.
Education includes a doctorate from Otago Medical School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
09/06/2026 5 405 ( 0,01 % ) 16 810 $ 30/06/2026

Postes actifs de Catherine Bollard

SociétésPosteDébut
CABALETTA BIO, INC. Directeur/Membre du Conseil 02/04/2019
Corporate Officer/Principal 01/01/2013
Corporate Officer/Principal 01/01/2013
Directeur/Membre du Conseil 01/01/2023

Anciens postes connus de Catherine Bollard

SociétésPosteFin
Corporate Officer/Principal 01/01/2013
Fondateur -
Directeur/Membre du Conseil -
President -
GW Cancer Center
Corporate Officer/Principal -
Voir l'expérience en détail de Catherine Bollard

Formation de Catherine Bollard

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

80

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Consumer Services

Commercial Services

Health Services

Consumer Services

Children's Research Institute, Inc.

Health Services

Health Technology

GW Cancer Center

Commercial Services

Consumer Services

  1. Bourse
  2. Insiders
  3. Catherine Bollard
🔇